Technical Analysis for IMM - Immutep Limited

Grade Last Price % Change Price Change
B 0.380 2.70% 0.010
IMM closed up 2.7 percent on Thursday, March 28, 2024, on 62 percent of normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Gapped Down Weakness 0.00%
Fell Below 20 DMA Bearish 2.70%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.70%
Gapped Down Weakness 2.70%
20 DMA Support Bullish -1.30%
Doji - Bearish? Reversal -1.30%
Gapped Up Strength -1.30%
Narrow Range Bar Range Contraction 0.00%

   Recent Intraday Alerts

Alert Time
Up 3% about 15 hours ago
Rose Above 20 DMA about 16 hours ago
Up 2% about 16 hours ago
20 DMA Resistance about 18 hours ago
10 DMA Resistance about 20 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Immutep Limited Description

Immutep Ltd, formerly Prima BioMed Ltd., is a biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment. Its core technologies are based on the Lymphocyte-activation gene 3 (LAG-3) immune control mechanism, which is involved in regulation of the T cell immune response. Its product, IMP321, is in clinical development for the treatment of a range of cancer indications, such as Metastatic Breast Cancer. IMP321 is in Phase IIb trials for Metastatic Breast Cancer and is being studied in Phase I for the treatment of Metastatic Melanoma. The Company is also focused on development of other products, which include IMP701, an antibody for cancer, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Medicine Biotechnology Cancer Therapeutic Product Therapy Breast Cancer Therapeutic Products Biomed Cancer Immunotherapy Melanoma Immunotherapeutic Products Medical Biotechnology Metastatic Breast Cancer

Is IMM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.42
52 Week Low 0.225
Average Volume 941,239
200-Day Moving Average 0.319
50-Day Moving Average 0.362
20-Day Moving Average 0.378
10-Day Moving Average 0.375
Average True Range 0.016
RSI (14) 53.05
ADX 15.35
+DI 20.666
-DI 19.352
Chandelier Exit (Long, 3 ATRs) 0.368
Chandelier Exit (Short, 3 ATRs) 0.389
Upper Bollinger Bands 0.405
Lower Bollinger Band 0.350
Percent B (%b) 0.54
BandWidth 14.728
MACD Line 0.005
MACD Signal Line 0.006
MACD Histogram -0.0008
Fundamentals Value
Market Cap 187.3 Million
Num Shares 493 Million
EPS -0.01
Price-to-Earnings (P/E) Ratio -63.33
Price-to-Sales 14.19
Price-to-Book 3.92
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.406
Resistance 3 (R3) 0.403 0.393 0.401
Resistance 2 (R2) 0.393 0.386 0.394 0.400
Resistance 1 (R1) 0.386 0.382 0.390 0.389 0.398
Pivot Point 0.376 0.376 0.377 0.377 0.376
Support 1 (S1) 0.369 0.369 0.373 0.372 0.362
Support 2 (S2) 0.359 0.365 0.360 0.360
Support 3 (S3) 0.352 0.359 0.359
Support 4 (S4) 0.355